No not at all
QUAGEN is mentioned in the first of the announce
Ellume’s partnerships with GSK and QIAGEN validates successful global Point of Care (POC) strategy•Ellume and Anteo collaboration confirms performance enhancing capabilities of AnteoBind for POC
(from announcement)
So obviously anteobind will be used. .Why not expect some payment.
DEALROOM
New Feature Announcement!
We’re excited to introduce the DealRoom portal, now live on site, providing users with exciting access to private equity opportunities for both pre-IPO and publicly listed companies.
See full details by selecting the new menu item named 'DealRoom' on our main menu bar or click below.
Stay ahead of the market, with HotCopper.